Orphazyme A's

Name: Orphazyme A Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ORPH Sales vs. its Competitors Q4 2021

Comparing the current results to its competitors, Orphazyme A reported Revenue increase in the 4 quarter 2021 by 0 % year on year.
The revenue growth was below Orphazyme A's competitors' average revenue growth of 25162.12 %, achieved in the same quarter.

• List of ORPH Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Orphazyme A recorded a net loss, as well as most of its competitors.

<< ORPH Stock Performance Comparisons

<< See the full list of ORPH competitors

*Market share is calculated based on total revenue.

ORPH's Stock Performance relative to its Competitors

Publicly Traded Peers of Orphazyme A

Cyclo Therapeutics Inc
Share Performance

-10.14%

30 Days

Cyclo Therapeutics Inc

Profile

Cyclo Therapeutics Inc is a biotechnology company that focuses on developing innovative treatments for rare and life-threatening diseases. Their business model involves conducting research, developing therapeutic solutions using their proprietary technology, and eventually commercializing these therapies through partnerships or direct sales.

More about Cyclo Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 20.703 mill.	$ 0.871 mill.	$ -18.819 mill.

Sources: Orphazyme A’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, August 30, 2026 9:35 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Orphazyme A versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.